one item that caught my eye was the
statement <em>" current data suggest that retreating patients with genotype 2 or 3 for a long
er duration does not affect SVR because 24 and 48 weeks of
therapy yield similar rates of
SVR"</em> and they cite <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed">Hadziyannis'06</a>.
My hunch is that the 800mg of
the good stuff may have been a significant factor.